Financhill
Back

AbbVie 10K Form

Buy
60

ABBV
AbbVie

Last Price:
155.27
Seasonality Move:
5.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive ABBV News And Ratings

See the #1 stock for the next 7 days that we like better than ABBV

ABBV Financial Statistics

Sales & Book Value

Annual Sales: $58.05B
Cash Flow: $7.22B
Price / Cash Flow: 11.27
Annual Sales: $9.75
Price / Book: 15.76

Profitability

EPS (TTM): 6.61000
Net Income (TTM): $11.84B
Gross Margin: $40.64B
Return on Equity: 74.35%
Return on Assets: 8.3%

AbbVie Earnings Forecast

Key AbbVie Financial Ratios

  • The Gross Profit Margin over the past 14 years for ABBV is 70.00%.
  • The Selling, General & Administrative Expenses for ABBV have been equal to 26.29% of Gross Profit Margin.
  • The Research & Development expenses have been 11.21% of Revenue.
  • The Interest Expense is 18.84% of Operating Income.
  • The Net Earning history of ABBV is 20.39% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 7 years.

AbbVie Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Drug Manufacturers - General
Sector: Healthcare
Current Symbol: ABBV
CUSIP: 00287Y
Website: abbvieinvestor.com

Debt

Debt-to-Equity Ratio: 3.67
Current Ratio: 0.96
Quick Ratio: 0.69

Price-to-Earnings

Trailing P/E Ratio: 23.18
Forward P/E Ratio: 13.84

ABBV Technical Analysis vs Fundamental Analysis

Buy
60
AbbVie (ABBV) is a Buy

Is AbbVie a Buy or a Sell?

  • AbbVie stock is rated a Buy
    The current AbbVie [ABBV] share price is $153.67. The Score for ABBV is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.